What's New with St. Jude Medical?
The FTC (Federal Trade Commission) has approved the $25 billion acquisition of St. Jude Medical (STJ) by Abbott Laboratories (ABT) subject to certain conditions.
Claris Injectables’ portfolio is expected to complement Baxter’s leading presence in the renal and hospital products segment.
The merger deal between Abbott Laboratories (ABT) and Alere (ALR) has become an extended battle, and Wall Street analysts have been closely watching the ongoing developments in this deal.
On December 7, 2016, Scott Stoffel, divisional vice president of external communications at Abbott Laboratories, noted, “Alere is no longer the company Abbott agreed to buy 10 months ago.”
Three months after announcing a $5.8 billion deal in which Abbott Laboratories (ABT) would buy Alere (ALR), Alere rejected Abbott’s $50 million offer to end the deal. On December 7, Abbott sued Alere to terminate the deal.
As of December 2, 2016, Sherwin-Williams’s one-year forward EV-to-EBITDA stood at 11.9x, while PPG’s was 10.4x.
Negative bond yields in Japan and the Eurozone, coupled with very low federal funds rates in the United States, are part of why emerging market bonds and currencies have performed so well in 2016.
Relative strength is something that we have used for almost 30 years. It is a methodology of simply dividing one thing by another.
Although the markets have surged to record highs in the last two months, there are early warning signs you should watch. The recent decline came on Friday, September 9.
Volatility (VXX) (XIV) typically moves higher in the latter part of the year, especially in September and October, and gradually recedes after that.
The relationship between the CBOE Volatility Index (or VIX) and the spread between high-yield bonds over ten-year Treasuries is highly correlated.
There are reasons to be hopeful that the recently improved tone in the economic data could persist over the second half of 2016.
The three US equity indexes that we review in this weekly series rose from August 2–9, 2016, due to a lack of attractive investment alternatives.
Asset managers and hedge funds have made gains from Brexit. Macro strategies and shorting the pound or a rush to safe-haven gold have reaped gains for hedge funds.
Among the options for investing in high-dividend yield stocks, dividend mutual funds pay out a dividend at regular intervals to their fund holders. They hold a basket of equities that pay dividends.
Since insurance companies are highly dependent on their ability to generate interest income, rising interest rates can significantly boost profits.
A hike in interest rates increases the cost of borrowing for companies. Most publicly traded companies carry at least some debt to fund their operations, and higher borrowing costs can cause their profit margins to contract.
The ALPS Sector Dividend Dogs ETF (SDOG), which applies the “Dogs of the Dow” dividend strategy on a sector-by-sector basis to stocks trading in the S&P 500, has risen by 14.0% on a YTD basis.
Some smart beta funds have outperformed the S&P 500 and may continue to do so. Also, the fees of smart beta funds are lower than those of traditional active management funds.
With Brexit turning into a reality, the Fed (Federal Reserve) may hold off raising interest rates in 2016 due to the slowing economy, the weak labor market, and subdued inflation.